Remove 2018 Remove FDA Remove Public Health
article thumbnail

CareCloud CEO predicts what's around the corner for telehealth

Healthcare It News

What's less certain, however, is what that utilization will look like in the future, particularly as the end of the public health emergency looms. We launched our first fully integrated telehealth solution in the 2018-2019 timeframe. First of all, we should think about the public health emergency.

COVID-19 340
article thumbnail

How Will New FDA Hearing Aid Regulations Impact Health Plans?

HIT Consultant

First, let’s examine the new regulatory framework the FDA established. Health plans should be on the alert for potential pitfalls arising from the new regulations. Health plans can design hearing benefits that can mitigate this potential issue while maximizing member satisfaction at the same time. Introducing OTC hearing aids.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The FDA Releases New Draft Guidance on Considering Health Care Disparities When Reviewing Proposed Devices

C&M Health Law

Food and Drug Administration (FDA) released a draft guidance that, if finalized, will update the agency’s 2018 guidance on its Breakthrough Devices Program (the “Program”). If this latest draft guidance is finalized after a period of public comment, the agency will incorporate the proposed language into the 2018 guidance.

FDA 52
article thumbnail

In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts

Health Populi

paid for prescription drugs in 2018, with roughly four times the number of health citizens. More philanthropic organizations targeting neglected tropical and public health diseases. The first FDA cleared DTx was reSET from Pear Therapeutics, cleared in November 2018. using consumer-generated technology.

article thumbnail

Remanufacturing or Servicing of Medical Devices: FDA Issues Final Guidance Providing Additional Clarification

Hall Render

Food and Drug Administration (“FDA”) issued a Final Guidance titled “Remanufacturing of Medical Devices,” clarifying the definition of “remanufacturing” for reusable medical devices in need of maintenance or repair (“Final Guidance”). In May 2024, the U.S. Below are some highlights from the Final Guidance.

FDA 40
article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

The quickly evolving COVID-19 public health emergency has warranted the growing use of telehealth and non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and possible exposure to the virus. iRhythm Technologies.

COVID-19 216
article thumbnail

HHS-OIG Excludes Theranos Founder and CEO from Federal Health Programs for 90 Years

HIPAA Journal

The FDA launched an investigation into Theranos that found that the allegations in Carreyrou’s article were correct. Theranos and Homes denied the allegations and threatened to sue Carreyrou; however, in 2018, Homes stepped down from her position as CEO, and following an FBI investigation the company was shut down.

Fraud 91